1643.HK
Strong SellSinkerModern Chinese Medicine Group Co., Ltd. · Healthcare · China · $68M
HKD 0.65 -2.3% · close 5 Oct · scored 6 Oct
Sinker: Weak, expensive and falling. Nothing here to keep it afloat.
Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
ABOUT MODERN CHINESE MEDICINE GROUP CO., LTD.
Read
Modern Chinese Medicine Group Co., Ltd. is engaged in the manufacturing and sale of traditional Chinese medicine (TCM) products in China. The company focuses on developing and commercializing a range of TCM products, leveraging traditional knowledge with modern pharmaceutical techniques. Its established brand and product portfolio in a culturally significant market provide a competitive advantage within the healthcare sector.
FINANCIAL SUMMARY (HKD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|---|
| Revenue | — | 468.3M | 403.2M | 250.8M | 170.1M | -28.6% | 232.8M |
| EPS (HKD) | 0.16 | 0.17 | 0.10 | 0.02 | -0.02 | -51.1% | -0.07 |
| Shares | — | 600.0M | 600.0M | 600.0M | 720.0M | +20.0% | 720.0M |
| Debt | — | 0.5M | 84.4K | 0.2M | 80.9K | -44.0% | 1.4M |
| Equity | — | 495.6M | 554.1M | 567.4M | 583.5M | 5.6% | — |
| Op CF | — | 147.4M | 9.9M | 69.1M | 5.0M | -67.6% | -126.1M |
| Inv CF | — | -12.9M | -4.9M | -135.3M | -39.4M | — | — |
| Fin CF | — | -10.2M | -0.4M | -0.2M | 34.5M | — | — |
Swung more than 96% of stocks we rank over the past year (103% a year).
How this is worked out
What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 1643.HK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 1643.HK | Modern Chinese Medicine Group Co., Ltd.(you) | $68M | 11 | Strong Sell |
| 7630.HK | IMPACT Therapeutics, Inc | $494M | 20 | Sell |
| 301096.SZ | Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. | $785M | 10 | Strong Sell |
| 9637.HK | Alebund Pharmaceuticals (Jiangsu) Limited | $1.1B | 7 | Strong Sell |
| 600666.SS | Aurora Optoelectronics Co.,Ltd. | $1.3B | 9 | Strong Sell |
| 2630.HK | Vigonvita Life Sciences Co., Ltd. | $1.7B | 14 | Strong Sell |
| 300006.SZ | Chongqing Lummy Pharmaceutical Co., Ltd. | $857M | 29 | Sell |
| 6915.HK | Jiangxi Institute of Biological Products Inc. | $481M | 42 | Hold |
| 301507.SZ | Hangzhou Minsheng Healthcare Co., Ltd. | $699M | 39 | Hold |
| 000908.SZ | CSPC Hunan Jingfeng Pharmaceutical Co., Ltd. | $1.6B | 23 | Sell |
Peer medians: ROE 4.3% · P/E 27.8x · Gross margin 53.0%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.